Open Access

ARTICLE

Inhibitors of PI3K/ERK1/2/p38 MAPK Show Preferential Activity Against Endocrine-Resistant Breast Cancer Cells

Maitham A. Khajah, Princy M. Mathew, Yunus A. Luqmani

Faculty of Pharmacy, Kuwait University, Safat, Kuwait